Small changes, big impact: Posttranslational modifications and function of huntingtin in huntington disease

Neuroscientist

Volumn 17, Issue 5, 2011, Pages 475-492

  Ehrnhoefer, Dagmar E ^a   Sutton, Liza ^a   Hayden, Michael R ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

huntingtin function; Huntington disease; neurodegeneration; posttranslational modification; therapeutic targets

Indexed keywords

CALPAIN; CASPASE 6; HUNTINGTIN; I KAPPA B KINASE; POLYGLUTAMINE;

ACETYLATION; ARTICLE; HUMAN; HUNTINGTON CHOREA; PALMITOYLATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SUMOYLATION; UBIQUITINATION;

ACETYLATION; ANIMALS; BRAIN; HUMANS; HUNTINGTON DISEASE; LIPOYLATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SUMOYLATION; UBIQUITINATION;

EID: 80053573543     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858410390378     Document Type: Article

References (139)

1. Aiken CT, Steffan JS, Guerrero CM, Khashwji H, Lukacsovich T, Simmons D. Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity. J Biol Chem. 2009 ; 284 (43). 29427-36
2. Albin RL, Young AB, Penney JB, Handelin B, Balfour R, Anderson KD. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease. N Engl J Med. 1990 ; 322 (18). 1293-8 (Pubitemid 20152493)
3. Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol. 2007 ; 170 (4). 1200-9 (Pubitemid 47339328)
4. Anne SL, Saudou F, Humbert S. Phosphorylation of huntingtin by cyclin-dependent kinase 5 is induced by DNA damage and regulates wild-type and mutant huntingtin toxicity in neurons. J Neurosci. 2007 ; 27 (27). 7318-28 (Pubitemid 47037570)
5. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature. 2004 ; 431 (7010). 805-10 (Pubitemid 39434070)
6. Baquet ZC, Gorski JA, Jones KR. Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor. J Neurosci. 2004 ; 24 (17). 4250-8 (Pubitemid 38620801)
7. Berke SJ, Schmied FA, Brunt ER, Ellerby LM, Paulson HL. Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. J Neurochem. 2004 ; 89 (4). 908-18 (Pubitemid 38684738)
8. Bessert DA, Gutridge KL, Dunbar JC, Carlock LR. The identification of a functional nuclear localization signal in the Huntington disease protein. Brain Res Mol Brain Res. 1995 ; 33 (1). 165-73
9. Bhattacharyya A, Thakur AK, Chellgren VM, Thiagarajan G, Williams AD, Chellgren BW. Oligoproline effects on polyglutamine conformation and aggregation. J Mol Biol. 2006 ; 355 (3). 524-35 (Pubitemid 41785754)
10. Bock PE, Panizzi P, Verhamme IM. Exosites in the substrate specificity of blood coagulation reactions. J Thromb Haemost 5 Suppl. 2007 ; 1: 81-94 (Pubitemid 46958821)
11. Caviston JP, Ross JL, Antony SM, Tokito M, Holzbaur EL. Huntingtin facilitates dynein/dynactin-mediated vesicle transport. Proc Natl Acad Sci U S A. 2007 ; 104 (24). 10045-50 (Pubitemid 47175260)
12. Chan HY, Warrick JM, Andriola I, Merry D, Bonini NM. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum Mol Genet. 2002 ; 11 (23). 2895-904
13. Chen HK, Fernandez-Funez P, Acevedo SF, Lam YC, Kaytor MD, Fernandez MH. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell. 2003 ; 113 (4). 457-68 (Pubitemid 36588749)
14. Choo YS, Johnson GV, MacDonald M, Detloff PJ, Lesort M. Mutant huntingtin directly increases susceptibility of mitochondria to the calcium-induced permeability transition and cytochrome c release. Hum Mol Genet. 2004 ; 13 (14). 1407-20 (Pubitemid 39023049)
15. Colin E, Zala D, Liot G, Rangone H, Borrell-Pages M, Li XJ. Huntingtin phosphorylation acts as a molecular switch for anterograde/retrograde transport in neurons. EMBO J. 2008 ; 27 (15). 2124-34
16. Colomer Gould VF, Goti D, Pearce D, Gonzalez GA, Gao H, Bermudez de Leon M. A mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado-Joseph disease-like transgenic mice. Neurobiol Dis. 2007 ; 27 (3). 362-9 (Pubitemid 47337189)
17. Crepaldi L, Riccio A. Chromatin learns to behave. Epigenetics. 2009 ; 4 (1). 23-6
18. Dalva MB. Neuronal activity moves protein palmitoylation into the synapse. J Cell Biol. 2009 ; 186 (1). 7-9
19. Dehay B, Bertolotti A. Critical role of the proline-rich region in Huntingtin for aggregation and cytotoxicity in yeast. J Biol Chem. 2006 ; 281 (47). 35608-15 (Pubitemid 46041291)
20. Denuc A, Marfany G. SUMO and ubiquitin paths converge. Biochem Soc Trans. 2010 ; 38 (Pt 1). 34-9
21. Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J. Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res. 2010 ; 214 (2). 193-200
22. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997 ; 277 (5334). 1990-3 (Pubitemid 27449140)
23. Dix MM, Simon GM, Cravatt BF. Global mapping of the topography and magnitude of proteolytic events in apoptosis. Cell. 2008 ; 134 (4). 679-91
24. Drisdel RC, Manzana E, Green WN. The role of palmitoylation in functional expression of nicotinic alpha7 receptors. J Neurosci. 2004 ; 24 (46). 10502-10 (Pubitemid 39552635)
25. Duvick LA, Barnes J, Ebner B, Agrawal S, Andresen M, Lim J. SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron. 2010 ; 67: 929-35
26. Ellerby LM, Andrusiak RL, Wellington CL, Hackam AS, Propp SS, Wood JD. Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. J Biol Chem. 1999 ; 274 (13). 8730-6 (Pubitemid 29164670)
27. Emamian ES, Kaytor MD, Duvick LA, Zu T, Tousey SK, Zoghbi HY. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron. 2003 ; 38 (3). 375-87 (Pubitemid 36579141)
28. Falk JD, Vargiu P, Foye PE, Usui H, Perez J, Danielson PE. Rhes: a striatal-specific Ras homolog related to Dexras1. J Neurosci Res. 1999 ; 57 (6). 782-8 (Pubitemid 29416108)
29. Fu M, Wang C, Reutens AT, Wang J, Angeletti RH, Siconolfi-Baez L. p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem. 2000 ; 275 (27). 20853-60 (Pubitemid 30457679)
30. Fukata Y, Fukata M. Protein palmitoylation in neuronal development and synaptic plasticity. Nat Rev Neurosci. 2010 ; 11 (3). 161-75
31. Gafni J, Ellerby LM. Calpain activation in Huntington's disease. J Neurosci. 2002 ; 22 (12). 4842-9 (Pubitemid 37465599)
32. Gafni J, Hermel E, Young JE, Wellington CL, Hayden MR, Ellerby LM. Inhibition of calpain cleavage of huntingtin reduces toxicity: accumulation of calpain/caspase fragments in the nucleus. J Biol Chem. 2004 ; 279 (19). 20211-20 (Pubitemid 38623466)
33. Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci U S A. 2006 ; 103 (18). 7130-5
34. Garden GA, Libby RT, Fu YH, Kinoshita Y, Huang J, Possin DE. Polyglutamine-expanded ataxin-7 promotes non-cell-autonomous purkinje cell degeneration and displays proteolytic cleavage in ataxic transgenic mice. J Neurosci. 2002 ; 22 (12). 4897-905 (Pubitemid 37465605)
35. Gauthier LR, Charrin BC, Borrell-Pages M, Dompierre JP, Rangone H, Cordelieres FP. Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules. Cell. 2004 ; 118 (1). 127-38 (Pubitemid 38902819)
36. Gines S, Ivanova E, Seong IS, Saura CA, MacDonald ME. Enhanced Akt signaling is an early pro-survival response that reflects N-methyl-D-aspartate receptor activation in Huntington's disease knock-in striatal cells. J Biol Chem. 2003 ; 278 (50). 50514-22 (Pubitemid 37548897)
37. Glozak MA, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proteins. Gene. 2005 ; 363: 15-23 (Pubitemid 41691888)
38. Goldberg YP, Nicholson DW, Rasper DM, Kalchman MA, Koide HB, Graham RK. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat Genet. 1996 ; 13 (4). 442-9 (Pubitemid 26256618)
39. Graham RK, Deng Y, Carroll J, Vaid K, Cowan C, Pouladi MA. Cleavage at the 586aa caspase-6 site in mutant huntingtin influences caspase-6 activation in vivo. J Neurosci.. 2010 ; 30 (45). 15019-29
40. Graham RK, Deng Y, Slow EJ, Haigh B, Bissada N, Lu G. Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin. Cell. 2006a ; 125 (6). 1179-91 (Pubitemid 43866195)
41. Graham RK, Slow EJ, Deng Y, Bissada N, Lu G, Pearson J. Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse models. Neurobiol Dis. 2006b ; 21 (2). 444-55 (Pubitemid 43099867)
42. Gray DC, Mahrus S, Wells JA. Activation of specific apoptotic caspases with an engineered small-molecule-activated protease. Cell. 2010 ; 142 (4). 637-46
43. Gu X, Greiner ER, Mishra R, Kodali R, Osmand A, Finkbeiner S. Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron. 2009 ; 64 (6). 828-40
44. Haacke A, Broadley SA, Boteva R, Tzvetkov N, Hartl FU, Breuer P. Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3. Hum Mol Genet. 2006 ; 15 (4). 555-68 (Pubitemid 43205421)
45. Haas KF, Broadie K. Roles of ubiquitination at the synapse. Biochim Biophys Acta. 2008 ; 1779 (8). 495-506
46. Hackam AS, Singaraja R, Wellington CL, Metzler M, McCutcheon K, Zhang T. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J Cell Biol. 1998 ; 141 (5). 1097-105 (Pubitemid 28265605)
47. Harjes P, Wanker EE. The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci. 2003 ; 28 (8). 425-33 (Pubitemid 36976745)
48. Hermel E, Gafni J, Propp SS, Leavitt BR, Wellington CL, Young JE. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Cell Death Differ. 2004 ; 11 (4). 424-38 (Pubitemid 38489420)
49. Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A. 2003 ; 100 (4). 2041-6 (Pubitemid 36254570)
50. Hoffner G, Kahlem P, Djian P. Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. J Cell Sci. 2002 ; 115 (Pt 5). 941-8 (Pubitemid 34257379)
51. Huang K, Kang MH, Askew C, Kang R, Sanders SS, Wan J. Palmitoylation and function of glial glutamate transporter-1 is reduced in the YAC128 mouse model of Huntington disease. Neurobiol Dis. 2010 ; 40 (1). 207-15
52. Huang K, Sanders S, Singaraja R, Orban P, Cijsouw T, Arstikaitis P. Neuronal palmitoyl acyl transferases exhibit distinct substrate specificity. FASEB J. 2009 ; 23 (8). 2605-15
53. Humbert S, Bryson EA, Cordelieres FP, Connors NC, Datta SR, Finkbeiner S. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell. 2002 ; 2 (6). 831-7 (Pubitemid 34650078)
54. Jana NR, Dikshit P, Goswami A, Kotliarova S, Murata S, Tanaka K. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes. J Biol Chem. 2005 ; 280 (12). 11635-40 (Pubitemid 40418477)
55. Jeong H, Then F, Melia TJ, Mazzulli JR, Cui L, Savas JN. Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell. 2009 ; 137 (1). 60-72
56. Jung J, Xu K, Lessing D, Bonini NM. Preventing ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3. Hum Mol Genet. 2009 ; 18 (24). 4843-52
57. Kalchman MA, Graham RK, Xia G, Koide HB, Hodgson JG, Graham KC. Huntingtin is ubiquitinated and interacts with a specific ubiquitin-conjugating enzyme. J Biol Chem. 1996 ; 271 (32). 19385-94 (Pubitemid 26271610)
58. Kang BS, Ahn JY, Kim MK, Kim HJ, Kang L, Lim HC. Heat shock protein 70 alters the endosome-lysosomal localization of huntingtin. Exp Mol Med. 2007 ; 39 (1). 38-46 (Pubitemid 46356004)
59. Keller TH, Pichota A, Yin Z. A practical view of 'druggability.'. Curr Opin Chem Biol. 2006 ; 10 (4). 357-61
60. Kim M, Lee HS, LaForet G, McIntyre C, Martin EJ, Chang P. Mutant huntingtin expression in clonal striatal cells: dissociation of inclusion formation and neuronal survival by caspase inhibition. J Neurosci. 1999 ; 19 (3). 964-73 (Pubitemid 29066159)
61. Kim YJ, Sapp E, Cuiffo BG, Sobin L, Yoder J, Kegel KB. Lysosomal proteases are involved in generation of N-terminal huntingtin fragments. Neurobiol Dis. 2006 ; 22 (2). 346-56
62. Kobayashi Y, Miwa S, Merry DE, Kume A, Mei L, Doyu M. Caspase-3 cleaves the expanded androgen receptor protein of spinal and bulbar muscular atrophy in a polyglutamine repeat length-dependent manner. Biochem Biophys Res Commun. 1998 ; 252 (1). 145-50 (Pubitemid 28534641)
63. Kruse JP, Gu W. Modes of p53 regulation. Cell. 2009 ; 137 (4). 609-22
64. Kurokawa M, Kornbluth S. Caspases and kinases in a death grip. Cell. 2009 ; 138 (5). 838-54
65. Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem. 2010 ; 285 (12). 8808-23
66. Landry Y, Gies JP. Drugs and their molecular targets: an updated overview. Fundam Clin Pharmacol. 2008 ; 22 (1). 1-18 (Pubitemid 351171284)
67. Leavitt BR, van Raamsdonk JM, Shehadeh J, Fernandes H, Murphy Z, Graham RK. Wild-type huntingtin protects neurons from excitotoxicity. J Neurochem. 2006 ; 96 (4). 1121-9
68. Levenson JM, O'Riordan KJ, Brown KD, Trinh MA, Molfese DL, Sweatt JD. Regulation of histone acetylation during memory formation in the hippocampus. J Biol Chem. 2004 ; 279 (39). 40545-59 (Pubitemid 39287646)
69. Li M, Chevalier-Larsen ES, Merry DE, Diamond MI. Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy. J Biol Chem. 2007 ; 282 (5). 3157-64 (Pubitemid 47084317)
70. Li W, Serpell LC, Carter WJ, Rubinsztein DC, Huntington JA. Expression and characterization of full-length human huntingtin, an elongated HEAT repeat protein. J Biol Chem. 2006 ; 281 (23). 15916-22 (Pubitemid 43848484)
71. Li Z, Jo J, Jia JM, Lo SC, Whitcomb DJ, Jiao S. Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. Cell. 2010 ; 141 (5). 859-71
72. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med. 2000 ; 6 (4). 397-404 (Pubitemid 30208156)
73. Lunkes A, Lindenberg KS, Ben-Haiem L, Weber C, Devys D, Landwehrmeyer GB. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell. 2002 ; 10 (2). 259-69 (Pubitemid 35007341)
74. Luo S, Vacher C, Davies JE, Rubinsztein DC. Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant huntingtin toxicity. J Cell Biol. 2005 ; 169 (4). 647-56 (Pubitemid 41002857)
75. Mahrus S, Trinidad JC, Barkan DT, Sali A, Burlingame AL, Wells JA. Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell. 2008 ; 134 (5). 866-76
76. Matsumoto M, Yada M, Hatakeyama S, Ishimoto H, Tanimura T, Tsuji S. Molecular clearance of ataxin-3 is regulated by a mammalian E4. EMBO J. 2004 ; 23 (3). 659-69 (Pubitemid 38282397)
77. McGuire JR, Rong J, Li SH, Li XJ. Interaction of Huntingtin-associated protein-1 with kinesin light chain: implications in intracellular trafficking in neurons. J Biol Chem. 2006 ; 281 (6). 3552-9 (Pubitemid 43845972)
78. Mende-Mueller LM, Toneff T, Hwang SR, Chesselet MF, Hook VY. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J Neurosci. 2001 ; 21 (6). 1830-7 (Pubitemid 32221366)
79. Metzler M, Gan L, Mazarei G, Graham RK, Liu L, Bissada N. Phosphorylation of huntingtin at Ser421 in YAC128 neurons is associated with protection of YAC128 neurons from NMDA-mediated excitotoxicity and is modulated by PP1 and PP2A. J Neurosci. 2010 ; 30 (43). 14318-29
80. Metzler M, Gan L, Wong TP, Liu L, Helm J, Georgiou J. NMDA receptor function and NMDA receptor-dependent phosphorylation of huntingtin is altered by the endocytic protein HIP1. J Neurosci. 2007 ; 27 (9). 2298-308 (Pubitemid 46340973)
81. Miller JP, Holcomb J, Al-Ramahi I, de Haro M, Gafni J, Zhang N. Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease. Neuron. 2010 ; 67 (2). 199-212
82. Milnerwood AJ, Gladding CM, Pouladi MA, Kaufman AM, Hines RM, Boyd JD. Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice. Neuron. 2010 ; 65 (2). 178-90
83. Miyashita T, Okamura-Oho Y, Mito Y, Nagafuchi S, Yamada M. Dentatorubral pallidoluysian atrophy (DRPLA) protein is cleaved by caspase-3 during apoptosis. J Biol Chem. 1997 ; 272 (46). 29238-42 (Pubitemid 27498216)
84. Mukherjee S, Thomas M, Dadgar N, Lieberman AP, Iniguez-Lluhi JA. Small ubiquitin-like modifier (SUMO) modification of the androgen receptor attenuates polyglutamine-mediated aggregation. J Biol Chem. 2009 ; 284 (32). 21296-306
85. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature. 2009 ; 457 (7232). 981-9
86. Nishida T, Yasuda H. PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription. J Biol Chem. 2002 ; 277 (44). 41311-7 (Pubitemid 35257430)
87. Noritake J, Fukata Y, Iwanaga T, Hosomi N, Tsutsumi R, Matsuda N. Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95. J Cell Biol. 2009 ; 186 (1). 147-60
88. Novak MJ, Tabrizi SJ. Huntington's disease. BMJ. 2010 ; 340: c3109
89. Okamoto S, Pouladi MA, Talantova M, Yao D, Xia P, Ehrnhoefer DE. Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin. Nat Med. 2009 ; 15 (12). 1407-13
90. Palazzolo I, Burnett BG, Young JE, Brenne PL, La Spada AR, Fischbeck KH. Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet. 2007 ; 16 (13). 1593-603 (Pubitemid 47050673)
91. Park KJ, Grosso CA, Aubert I, Kaplan DR, Miller FD. p75NTR-dependent, myelin-mediated axonal degeneration regulates neural connectivity in the adult brain. Nat Neurosci. 2010 ; 13 (5). 559-66
92. Pedram A, Razandi M, Sainson RC, Kim JK, Hughes CC, Levin ER. A conserved mechanism for steroid receptor translocation to the plasma membrane. J Biol Chem. 2007 ; 282 (31). 22278-88 (Pubitemid 47267344)
93. Pennuto M, Palazzolo I, Poletti A. Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity. Hum Mol Genet. 2009 ; 18 (R1). R40-7
94. Pineda JR, Pardo R, Zala D, Yu H, Humbert S, Saudou F. Genetic and pharmacological inhibition of calcineurin corrects the BDNF transport defect in Huntington's disease. Mol Brain. 2009 ; 2 (1). 33
95. Poukka H, Karvonen U, Janne OA, Palvimo JJ. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). Proc Natl Acad Sci U S A. 2000 ; 97 (26). 14145-50 (Pubitemid 32016544)
96. Preisinger E, Jordan BM, Kazantsev A, Housman D. Evidence for a recruitment and sequestration mechanism in Huntington's disease. Philos Trans R Soc Lond B Biol Sci. 1999 ; 354 (1386). 1029-34 (Pubitemid 29477964)
97. Rakhilin S, Drisdel RC, Sagher D, McGehee DS, Vallejo Y, Green WN. alpha-bungarotoxin receptors contain alpha7 subunits in two different disulfide-bonded conformations. J Cell Biol. 1999 ; 146 (1). 203-18
98. Rangone H, Poizat G, Troncoso J, Ross CA, MacDonald ME, Saudou F. The serum- and glucocorticoid-induced kinase SGK inhibits mutant huntingtin-induced toxicity by phosphorylating serine 421 of huntingtin. Eur J Neurosci. 2004 ; 19 (2). 273-9 (Pubitemid 38177866)
99. Ratovitski T, Gucek M, Jiang H, Chighladze E, Waldron E, D'Ambola J. Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J Biol Chem. 2009 ; 284 (16). 10855-67
100. Ratovitski T, Nakamura M, D'Ambola J, Chighladze E, Liang Y, Wang W. N-terminal proteolysis of full-length mutant huntingtin in an inducible PC12 cell model of Huntington's disease. Cell Cycle. 2007 ; 6 (23). 2970-81
101. Rockabrand E, Slepko N, Pantalone A, Nukala VN, Kazantsev A, Marsh JL. The first 17 amino acids of Huntingtin modulate its sub-cellular localization, aggregation and effects on calcium homeostasis. Hum Mol Genet. 2007 ; 16 (1). 61-77 (Pubitemid 46156597)
102. Rouaux C, Jokic N, Mbebi C, Boutillier S, Loeffler JP, Boutillier AL. Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration. EMBO J. 2003 ; 22 (24). 6537-49 (Pubitemid 38009601)
103. Ryu J, Cho S, Park BC, Lee do H. Oxidative stress-enhanced SUMOylation and aggregation of ataxin-1: implication of JNK pathway. Biochem Biophys Res Commun. 2010 ; 393 (2). 280-5
104. Saudou F, Finkbeiner S, Devys D, Greenberg ME. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell. 1998 ; 95 (1). 55-66
105. Schilling B, Gafni J, Torcassi C, Cong X, Row RH, LaFevre-Bernt MA. Huntingtin phosphorylation sites mapped by mass spectrometry: modulation of cleavage and toxicity. J Biol Chem. 2006 ; 281 (33). 23686-97 (Pubitemid 44274144)
106. Schmidtke P, Barril X. Understanding and predicting druggability: a high-throughput method for detection of drug binding sites. J Med Chem. 2010 ; 53 (15). 5858-67
107. Schoenmann Z, Assa-Kunik E, Tiomny S, Minis A, Haklai-Topper L, Arama E. Axonal degeneration is regulated by the apoptotic machinery or a NAD+-sensitive pathway in insects and mammals. J Neurosci. 2010 ; 30 (18). 6375-86
108. Sherbenou DW, Druker BJ. Applying the discovery of the Philadelphia chromosome. J Clin Invest. 2007 ; 117 (8). 2067-74 (Pubitemid 47219546)
109. Slow EJ, Graham RK, Osmand AP, Devon RS, Lu G, Deng Y. Absence of behavioral abnormalities and neurodegeneration in vivo despite widespread neuronal huntingtin inclusions. Proc Natl Acad Sci U S A. 2005 ; 102 (32). 11402-7 (Pubitemid 41153832)
110. Southwell AL, Khoshnan A, Dunn DE, Bugg CW, Lo DC, Patterson PH. Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity. J Neurosci. 2008 ; 28 (36). 9013-20
111. Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N. SUMO modification of Huntingtin and Huntington's disease pathology. Science. 2004 ; 304 (5667). 100-4 (Pubitemid 38451465)
112. Strehlow AN, Li JZ, Myers RM. Wild-type huntingtin participates in protein trafficking between the Golgi and the extracellular space. Hum Mol Genet. 2007 ; 16 (4). 391-409 (Pubitemid 46323176)
113. Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, Swaroop M. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat Genet. 1993 ; 5 (3). 259-65 (Pubitemid 23330389)
114. Subramaniam S, Sixt KM, Barrow R, Snyder SH. Rhes, a striatal specific protein, mediates mutant-huntingtin cytotoxicity. Science. 2009 ; 324 (5932). 1327-30
115. Tan JA, Song J, Chen Y, Durrin LK. Phosphorylation-dependent interaction of SATB1 and PIAS1 directs SUMO-regulated caspase cleavage of SATB1. Mol Cell Biol. 2010 ; 30 (11). 2823-36
116. Terashima T, Kawai H, Fujitani M, Maeda K, Yasuda H. SUMO-1 co-localized with mutant atrophin-1 with expanded polyglutamines accelerates intranuclear aggregation and cell death. Neuroreport. 2002 ; 13 (17). 2359-64 (Pubitemid 36044459)
117. Thompson LM, Aiken CT, Kaltenbach LS, Agrawal N, Illes K, Khoshnan A. IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol. 2009 ; 187 (7). 1083-99
118. Trushina E, McMurray CT. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience. 2007 ; 145 (4). 1233-48 (Pubitemid 46602738)
119. Tsai LH, Takahashi T, Caviness VS, Harlow E. Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. Development. 1993 ; 119 (4). 1029-40 (Pubitemid 23358574)
120. Tsai YC, Fishman PS, Thakor NV, Oyler GA. Parkin facilitates the elimination of expanded polyglutamine proteins and leads to preservation of proteasome function. J Biol Chem. 2003 ; 278 (24). 22044-55 (Pubitemid 36792614)
121. Ueda H, Goto J, Hashida H, Lin X, Oyanagi K, Kawano H. Enhanced SUMOylation in polyglutamine diseases. Biochem Biophys Res Commun. 2002 ; 293 (1). 307-13 (Pubitemid 34694207)
122. Walsh R, Storey E, Stefani D, Kelly L, Turnbull V. The roles of proteolysis and nuclear localisation in the toxicity of the polyglutamine diseases: a review. Neurotox Res. 2005 ; 7 (1-2). 43-57
123. Wang XJ, Cao Q, Liu X, Wang KT, Mi W, Zhang Y. Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation. EMBO Rep. 2010 ; 11: 841-7
124. Warby SC, Chan EY, Metzler M, Gan L, Singaraja RR, Crocker SF. Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. Hum Mol Genet. 2005 ; 14 (11). 1569-77 (Pubitemid 40823464)
125. Warby SC, Doty CN, Graham RK, Carroll JB, Yang YZ, Singaraja RR. Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus. Hum Mol Genet. 2008 ; 17 (15). 2390-404
126. Warby SC, Doty CN, Graham RK, Shively J, Singaraja RR, Hayden MR. Phosphorylation of huntingtin reduces the accumulation of its nuclear fragments. Mol Cell Neurosci. 2009 ; 40 (2). 121-7
127. Wellington CL, Ellerby LM, Hackam AS, Margolis RL, Trifiro MA, Singaraja R. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J Biol Chem. 1998 ; 273 (15). 9158-67 (Pubitemid 28176206)
128. Wellington CL, Hayden MR. Caspases and neurodegeneration: on the cutting edge of new therapeutic approaches. Clin Genet. 2000 ; 57 (1). 1-10 (Pubitemid 30105555)
129. Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem. 2000 ; 275 (26). 19831-8 (Pubitemid 30441585)
130. Wilkinson KA, Nakamura Y, Henley JM. Targets and consequences of protein SUMOylation in neurons. Brain Res Rev. 2010 ; 64 (1). 195-212
131. Xia J, Lee DH, Taylor J, Vandelft M, Truant R. Huntingtin contains a highly conserved nuclear export signal. Hum Mol Genet. 2003 ; 12 (12). 1393-403 (Pubitemid 36758452)
132. Xie Y, Hayden MR, Xu B. BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice. J Neurosci. :
133. Yanai A, Huang K, Kang R, Singaraja RR, Arstikaitis P, Gan L. Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function. Nat Neurosci. 2006 ; 9 (6). 824-31
134. Yang XJ, Seto E. Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol Cell. 2008 ; 31 (4). 449-61
135. Young JE, Gouw L, Propp S, Sopher BL, Taylor J, Lin A. Proteolytic cleavage of ataxin-7 by caspase-7 modulates cellular toxicity and transcriptional dysregulation. J Biol Chem. 2007 ; 282 (41). 30150-60 (Pubitemid 350035251)
136. Zala D, Colin E, Rangone H, Liot G, Humbert S, Saudou F. Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum Mol Genet. 2008 ; 17 (24). 3837-46 (Pubitemid 352762847)
137. Zeron MM, Hansson O, Chen N, Wellington CL, Leavitt BR, Brundin P. Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease. Neuron. 2002 ; 33 (6). 849-60 (Pubitemid 34246352)
138. Zhang Y, Li M, Drozda M, Chen M, Ren S, Mejia Sanchez RO. Depletion of wild-type huntingtin in mouse models of neurologic diseases. J Neurochem. 2003 ; 87 (1). 101-6 (Pubitemid 37210644)
139. Zuchner T, Brundin P. Mutant huntingtin can paradoxically protect neurons from death. Cell Death Differ. 2008 ; 15 (3). 435-42 (Pubitemid 351267294)